Authorized generics vs. branded generics: A perspective

2020 ◽  
pp. 174113432094777
Author(s):  
Bharti Latwal ◽  
Amrish Chandra
Keyword(s):  
Lower Cost ◽  
Brand Name ◽  
Drug Companies ◽  
Generic Medications ◽  
Branded Drugs ◽  
The Masses ◽  
Brand Name Drugs ◽  
Day By Day

Nowadays, there are many generic medications available in the market. Their sale is increasing day by day due to their lower cost and affordability by most of the customers. Generic medications are pharmaceuticals that are therapeutically equivalent to an original off patent drug. Both authorized generics and branded generics are the versions of generic medications. They offer lucrative business and increase competition for ordinary generics. They supply medications having quality of branded drugs at lower prices and this establishes their recognition among the masses who earlier has limited options to buy only brand-name drugs. They are cheaper than brand name drugs but costlier than ordinary generics. Authorized generics are sold only by Innovator Companies but the branded generics can be sold by both innovator companies and generic companies. They both are different from one another and have their own impact on the brand drug companies, generic companies and consumers.

scholarly journals Perception on generic drugs among general populace visiting a community pharmacy Jaipur, Rajasthan

2018 ◽  
Vol 8 (6) ◽  
pp. 192-194 ◽  
Author(s):  
Sarita Jangra ◽  
Bhupinder Bhyan ◽  
Aprna Nair
Keyword(s):  
Community Pharmacy ◽  
Healthcare Costs ◽  
Generic Drugs ◽  
Primary Source ◽  
Brand Name ◽  
Branded Drugs ◽  
The Difference ◽  
The Government ◽  
Brand Name Drugs

Healthcare costs have been leading cause of poverty for many Indians. One of the solutions to this is to advocate generic drugs which are cheaper in comparison to brand name drugs. The government of India had made it mandatory for physicians to use only generic names while prescribing. This study was conducted to analyze the perception of general public in Jaipur, Rajasthan towards generic drugs. A simple close ended questionnaire was administered to selected participants visiting a community pharmacy over a period of 3 months. Patients were asked about their opinions on effectiveness and government promotion of generic substitutions. In the study consisting of 100 participants 92 of them had heard of generic drugs while 76% knew the difference between generic and branded drugs. 47.8% believed that brand name drugs were more effective than generic while 34.7% believed in lower quality of generic drugs. Only 30.4% of participants were aware of government’s efforts to promote generic drugs. 65% confirmed that they would prefer a generic drug only if it were recommended by a physician and not a pharmacist. Majority of participants had their primary source of information as social media. The result from study suggests that in order to reduce overall healthcare costs of Indians the government must ensure to include all healthcare professionals with physicians as primary informer and also include campaigns through social Medias. Keywords: Healthcare costs, generic drugs, branded drugs, community pharmacy

scholarly journals Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review

PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e23611 ◽  
Author(s):  
Amélie van der Meersch ◽  
Agnès Dechartres ◽  
Philippe Ravaud
Keyword(s):  
Systematic Review ◽  
Brand Name ◽  
Quality Of Reporting ◽  
Brand Name Drugs

scholarly journals Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?

2018 ◽  
Vol 10 (1S) ◽  
pp. 75-80
Author(s):  
E. A. Ushkalova ◽  
S. K. Zyryanov ◽  
K. E. Zatolochina
Keyword(s):  
Cost Effectiveness ◽  
Antiepileptic Drugs ◽  
Economic Benefits ◽  
Brand Name ◽  
Regulatory Requirements ◽  
The Cost ◽  
Generic Instability ◽  
The Impact ◽  
Brand Name Drugs

A policy on generic substitutions, which is aimed at reducing the cost-effectiveness of pharmacotherapy, was proposed by the WHO at the end of the 20th century; however, but the debate about their  economic benefits has continued until now. There have been the  most active discussions of whether an epileptic patient may be  switched from brand-name to generic antiepileptic drugs. The paper  gives data obtained in Russian and foreign studies of the therapeutic  efficacy and safety of anticonvulsant generics versus their brand- name drugs, as well as the impact of generic substitutions on the cost-effectiveness of  antiepileptic therapy. Emphasis is placed on the importance of the  quality of generic medicines, their dosage forms, and regulatory requirements for registration of generics. The problem of generic instability is under discussion.

scholarly journals Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS)

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Anas Alfarsi ◽  
Céline Caillet ◽  
Garry Fawbert ◽  
Simon Lawrence ◽  
Jacob Krüse ◽  
...  
Keyword(s):  
Active Ingredient ◽  
Lower Cost ◽  
Principal Component ◽  
Acoustic Resonance ◽  
South East Asia ◽  
Acoustic Signatures ◽  
Falsified Medicines ◽  
Acoustic Phenomenon ◽  
The Eu

AbstractThe trade in falsified medicine has increased significantly and it is estimated that global falsified sales have reached $100 billion in 2020. The EU Falsified Medicines Directive states that falsified medicines do not only reach patients through illegal routes but also via the legal supply chain. Falsified medicines can contain harmful ingredients. They can also contain too little or too much active ingredient or no active ingredient at all. BARDS (Broadband Acoustic Resonance Dissolution Spectroscopy) harnesses an acoustic phenomenon associated with the dissolution of a sample (tablet or powder). The resulting acoustic spectrum is unique and intrinsic to the sample and can be used as an identifier or signature profile. BARDS was evaluated in this study to determine whether a product is falsified or genuine in a rapid manner and at lower cost than many existing technologies. A range of genuine and falsified medicines, including falsified antimalarial tablets from south-east Asia, were tested, and compared to their counterpart genuine products. Significant differences between genuine and falsified doses were found in their acoustic signatures as they disintegrate and dissolve. Principal component analysis was employed to differentiate between the genuine and falsified medicines. This demonstrates that the tablets and capsules included here have intrinsic acoustic signatures which could be used to screen the quality of medicines.

Using Key Characteristics to Balance Cost and Quality During Product Development

1997 ◽  
Author(s):  
Anna C. Thornton
Keyword(s):  
Product Development ◽  
Product Quality ◽  
Lower Cost ◽  
Process Variation ◽  
Aircraft Manufacturing ◽  
Product Features ◽  
Key Characteristics ◽  
Manufacturing Variation ◽  
Positive Return

Abstract Corporations are spending significant resources to reduce the effect of manufacturing variation on product quality as well as adopt lower cost manufacturing and assembly technologies to reduce the end costs in product development. However, to ensure that these investments have a positive return, efforts must be made to put resources into those areas where there will be the largest return. This paper describes a formalized method to make these decisions. The analysis focuses the tradeoff studies on the Key Characteristics (KCs) of the product. KCs, in use in a variety of industries, are the product features that are most sensitive to existing manufacturing and process variation and will affect the end quality of the product. Two examples from the aircraft manufacturing environment are used describe the application of the proposed methods.

scholarly journals Cost Minimisation Study of the Impact of Generic Drugs on Glaucoma Management: 1-year Indian Experience

1970 ◽  
Vol 12 (4) ◽  
pp. 192-196
Author(s):  
Devindra Sood ◽  
Alka Pandey ◽  
Rajeev Sood ◽  
Nagesh Gupta ◽  
Ravinder Kumar Bajaj ◽  
...  
Keyword(s):  
Generic Drugs ◽  
Open Angle Glaucoma ◽  
Eye Drops ◽  
Brand Name ◽  
Cost Difference ◽  
Medication Costs ◽  
Generic Medications ◽  
The Mean ◽  
The Cost ◽  
The Impact

Aim: To study the medication costs of various topical glaucoma medications using data collected from real world use by patients.Methods: Patients with primary open angle glaucoma treated at glaucoma clinics in 5 hospitals (1 rural and 4 urban) in northern India from 1 January to 30 June 2008 were enrolled. The number of days each bottle of medication lasted was recorded, and the mean cost per day was computed from the maximum retail price and mean number of days each medication lasted.Results: 790 of 801 eligible patients completed the study. The mean number of days that a bottle of medication lasted was found to be highest for Xalatan® and Xalacom® at 35.23 days and 35.00 days, respectively. The brand name prostaglandin analogues all lasted for a mean of more than 30 days: Xalatan, 35.23 days (SD, 4.14 days); Lumigan®, 31.37 days (SD, 5.31 days); and Travatan®, 34.84 days (SD, 6.51 days), while the generic eye drops lasted for about 21 days: latanoprost, 20.69 days (SD, 3.69 days) and bimatoprost, 21.39 days (SD, 4.34 days). The cost of the generic medication was less than the brand name medication in all groups (for example, bimatoprost, Indian rupees 9.76 versus Indian rupees 12.33) except for brimonidine/timolol (Indian rupees 8.73 versus Indian rupees 8.66). Further analysis in 2009 showed that, for latanoprost, brimonidine and brimonidine/timolol, the difference between the brand name and generic medications decreased in 2009 over 2008 (in the latanoprost group, the cost difference over the year reduced from Indian rupees 592 in 2008 to Indian rupees 523 in 2009); the cost difference for bimatoprost increased from 2008 to 2009.Conclusion: When both cost and number of days a bottle lasts were considered over the long term, use of generic medications might not minimise the cost of glaucoma medical management by much when compared with the brand name medication.

scholarly journals The Effects of the Consumer's Consumption Tendency on the Consumption Behavior of Customers visiting Hair salons

2021 ◽  
Vol 27 (5) ◽  
pp. 1238-1245
Author(s):  
Mi-Sun Ku ◽  
Seo-Heui Kim
Keyword(s):  
Quality Of Life ◽  
Consumption Patterns ◽  
Consumption Behavior ◽  
Beauty Salon ◽  
The Past ◽  
Rapid Economic Growth ◽  
Beauty Salons ◽  
And Behavior ◽  
Day By Day

As Korea's economic leeway has increased through rapid economic growth, the past simple consumption patterns for food, clothing, and shelter have changed from consumption patterns that invest for quality of life. This change in consumption has also affected the beauty industry, and competition in the beauty salon industry is getting fiercer day by day. Accordingly, it is judged that it is necessary to study the consumption propensity and behavior of customers visiting beauty salons in the current situation. Therefore, this study was conducted to find out whether consumption propensity affects consumption behavior by filling out a questionnaire targeting people in their 20s and 40s who have visited beauty salons. We want to provide the necessary basic data.

Sign in / Sign up

Export Citation Format

Share Document